Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
- PMID: 11844848
- DOI: 10.1056/NEJMoa011613
Plasma homocysteine as a risk factor for dementia and Alzheimer's disease
Abstract
Background: In cross-sectional studies, elevated plasma homocysteine levels have been associated with poor cognition and dementia. Studies of newly diagnosed dementia are required in order to establish whether the elevated homocysteine levels precede the onset of dementia or result from dementia-related nutritional and vitamin deficiencies.
Methods: A total of 1092 subjects without dementia (667 women and 425 men; mean age, 76 years) from the Framingham Study constituted our study sample. We examined the relation of the plasma total homocysteine level measured at base line and that measured eight years earlier to the risk of newly diagnosed dementia on follow-up. We used multivariable proportional-hazards regression to adjust for age, sex, apolipoprotein E genotype, vascular risk factors other than homocysteine, and plasma levels of folate and vitamins B12 and B6.
Results: Over a median follow-up period of eight years, dementia developed in 111 subjects, including 83 given a diagnosis of Alzheimer's disease. The multivariable-adjusted relative risk of dementia was 1.4 (95 percent confidence interval, 1.1 to 1.9) for each increase of 1 SD in the log-transformed homocysteine value either at base line or eight years earlier. The relative risk of Alzheimer's disease was 1.8 (95 percent confidence interval, 1.3 to 2.5) per increase of 1 SD at base line and 1.6 (95 percent confidence interval, 1.2 to 2.1) per increase of 1 SD eight years before base line. With a plasma homocysteine level greater than 14 micromol per liter, the risk of Alzheimer's disease nearly doubled.
Conclusions: An increased plasma homocysteine level is a strong, independent risk factor for the development of dementia and Alzheimer's disease.
Comment in
-
Homocysteine and dementias.N Engl J Med. 2002 Feb 14;346(7):466-8. doi: 10.1056/NEJM200202143460702. N Engl J Med. 2002. PMID: 11844846 No abstract available.
-
Elevated homocysteine: a new marker for dementia?CMAJ. 2002 Apr 16;166(8):1068. CMAJ. 2002. PMID: 12030205 Free PMC article. No abstract available.
-
Homocysteine and dementia.N Engl J Med. 2002 Jun 20;346(25):2007; author reply 2008. doi: 10.1056/NEJM200206203462514. N Engl J Med. 2002. PMID: 12075065 No abstract available.
-
Homocysteine and dementia.N Engl J Med. 2002 Jun 20;346(25):2007; author reply 2008. N Engl J Med. 2002. PMID: 12078704 No abstract available.
-
Elevated plasma total homocysteine levels increased the risk for dementia in the elderly.ACP J Club. 2002 Sep-Oct;137(2):76. ACP J Club. 2002. PMID: 12207454 No abstract available.
-
Elevated plasma total homocysteine increased the risk of dementia in the elderly.Evid Based Ment Health. 2002 Nov;5(4):126. doi: 10.1136/ebmh.5.4.126. Evid Based Ment Health. 2002. PMID: 12440468 No abstract available.
Similar articles
-
Homocysteine and folate as risk factors for dementia and Alzheimer disease.Am J Clin Nutr. 2005 Sep;82(3):636-43. doi: 10.1093/ajcn.82.3.636. Am J Clin Nutr. 2005. PMID: 16155278
-
Homocysteine levels and the risk of osteoporotic fracture.N Engl J Med. 2004 May 13;350(20):2033-41. doi: 10.1056/NEJMoa032546. N Engl J Med. 2004. PMID: 15141041
-
The methionine-homocysteine cycle and its effects on cognitive diseases.Altern Med Rev. 2003 Feb;8(1):7-19. Altern Med Rev. 2003. PMID: 12611557 Review.
-
Hypohomocysteinemia may increases the risk of dementia and Alzheimer's disease: A nationwide population-based prospective cohort study.Clin Nutr. 2021 Jul;40(7):4579-4584. doi: 10.1016/j.clnu.2021.05.034. Epub 2021 Jun 9. Clin Nutr. 2021. PMID: 34229262
-
The worldwide challenge of the dementias: a role for B vitamins and homocysteine?Food Nutr Bull. 2008 Jun;29(2 Suppl):S143-72. doi: 10.1177/15648265080292S119. Food Nutr Bull. 2008. PMID: 18709889 Review.
Cited by
-
Lactobacillus Eats Amyloid Plaque and Post-Biotically Attenuates Senescence Due to Repeat Expansion Disorder and Alzheimer's Disease.Antioxidants (Basel). 2024 Oct 12;13(10):1225. doi: 10.3390/antiox13101225. Antioxidants (Basel). 2024. PMID: 39456478 Free PMC article.
-
Peripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.J Neurovirol. 2016 Feb;22(1):22-32. doi: 10.1007/s13365-015-0357-8. Epub 2015 Jun 20. J Neurovirol. 2016. PMID: 26092111 Free PMC article. Review.
-
"Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.Neurotox Res. 2015 Jul;28(1):55-93. doi: 10.1007/s12640-015-9528-x. Epub 2015 Apr 25. Neurotox Res. 2015. PMID: 25911292 Review.
-
Relationships of B12 and Homocysteine with Outcomes in the SURE-PD, SURE-PD3, and STEADY-PDIII Trials.J Parkinsons Dis. 2024;14(6):1243-1255. doi: 10.3233/JPD-240035. J Parkinsons Dis. 2024. PMID: 39240650 Free PMC article. Clinical Trial.
-
Influence of vascular risk factors on executive function among an age-homogeneous elderly cohort.J Neural Transm (Vienna). 2015 Sep;122(9):1323-8. doi: 10.1007/s00702-015-1389-1. Epub 2015 Mar 11. J Neural Transm (Vienna). 2015. PMID: 25757983
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases